Clinical Trial Update: Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating armodafinil for reducing cancer-related fatigue in patients with high-grade glioma has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• High-grade Glioma

Drugs mentioned

• armodafinil (Nuvigil) (armodafinil)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Fatigue | Phase 3 | Status: COMPLETED | Results posted: 2020-05-07